Login / Signup

Not only a time-saving approach: Is it the time of subcutaneous formulation for daratumumab administration?

Gianluca PeregoGiorgia LongobardoCinzia VenezianoFrancesca FarinaMagda Marcatti
Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Keyphrases
  • multiple myeloma
  • drug delivery